Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SGLT-2 inhibitors in obesity and its associated cardiometabolic disorders: where do we stand?
Natalia G. Vallianou, Dimitrios Tsilingiris, Dimitris Kounatidis, et al.
Polskie Archiwum Medycyny Wewnętrznej (2022)
Open Access | Times Cited: 17

Showing 17 citing articles:

The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives
Natalia G. Vallianou, Dimitris Kounatidis, Dimitrios Tsilingiris, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6755-6755
Open Access | Times Cited: 57
Obesity and Peripheral Artery Disease: Current Evidence and Controversies
Ioannis G. Lempesis, Dimitrios Varrias, Μarios Sagris, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 264-279
Open Access | Times Cited: 30
Physiopathological mechanisms related to inflammation in obesity and type 2 diabetes mellitus
Ioannis G. Lempesis, Vasiliki Georgakopoulou
World Journal of Experimental Medicine (2023) Vol. 13, Iss. 3, pp. 7-16
Open Access | Times Cited: 24
Potential renoprotective effect of SGLT2 inhibitors against contrast-induced AKI in diabetic STEMI patients undergoing primary PCI
Barkın Kültürsay, Cemalettin Yılmaz, Barış Güven, et al.
Kardiologia Polska (2024) Vol. 82, Iss. 1, pp. 29-36
Open Access | Times Cited: 11
The Kidney in Obesity: Current Evidence, Perspectives and Controversies
Dimitris Kounatidis, Natalia G. Vallianou, Theodora Stratigou, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 4, pp. 680-702
Closed Access | Times Cited: 7
SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century?
Dimitris Kounatidis, Natalia G. Vallianou, Angelos Evangelopoulos, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2294-2294
Open Access | Times Cited: 20
The Many Facets of PPAR-γ Agonism in Obesity and Associated Comorbidities: Benefits, Risks, Challenges, and Future Directions
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome
Ioannis G. Lempesis, Samuel J. Apple, Gustavo Duarte, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 39, Iss. 6
Open Access | Times Cited: 14
The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity
Ioannis G. Lempesis, Jun‐Li Liu, Μaria Dalamaga
Metabolism Open (2022) Vol. 16, pp. 100220-100220
Open Access | Times Cited: 20
Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Nikolaos Spyrou, et al.
Current Obesity Reports (2023) Vol. 13, Iss. 1, pp. 1-34
Open Access | Times Cited: 11
Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches
Konstantinos Arvanitakis, Stavros P. Papadakos, Vasileios Lekakis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14704-14704
Open Access | Times Cited: 9
Implications of obesity and adiposopathy on respiratory infections; focus on emerging challenges
Ioannis G. Lempesis, Vasiliki Georgakopoulou
World Journal of Clinical Cases (2023) Vol. 11, Iss. 13, pp. 2925-2933
Open Access | Times Cited: 8
Role of metformin in the management of type 2 diabetes: recent advances
Carolina Gonzalez-Lopez, Brian S. Wojeck
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 7
Could exercise hormone irisin be a therapeutic agent against Parkinson’s and other neurodegenerative diseases?
Konstantinos Avgerinos, Junli Liu, Μaria Dalamaga
Metabolism Open (2023) Vol. 17, pp. 100233-100233
Open Access | Times Cited: 5
The role of kidney biopsy in deciphering diabetic versus non-diabetic origin of kidney disease among patients with type 2 diabetes mellitus and nephrotic range proteinuria: A retrospective study
Efstratios Kardalas, Aggeliki Paikopoulou, Dimitra A. Vassiliadi, et al.
Metabolism Open (2024) Vol. 23, pp. 100313-100313
Open Access
Relationship of vitamin D deficiency to cardiovascular disease and glycemic control in patients with type 2 diabetes mellitus: The Silesia Diabetes-Heart Project
Hanna Kwiendacz, Katarzyna Nabrdalik, Agata M. Wijata, et al.
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 1
Perspectives in vaccines, immune response, therapeutic interventions and COVID-19
Ιrene Karampela
Metabolism Open (2022) Vol. 17, pp. 100223-100223
Open Access
Page 1

Scroll to top